Menu
Not yet recruiting NCT06574308

Clinical Evaluation of the Scopio Cell Morphology Technology

— Observational Blood Cancer

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Blood cells classification.
Who it may be relevant to
Registry conditions: Blood Cancer. Basic parameters: 18 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Italy
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Clinical Evaluation of the Scopio Cell Morphology Technology on Pre-classification of Blood Cells in Peripheral Blood (PB) and Bone Marrow (BM)

Overview

Digital morphology is currently expanding and developing new applications based on artificial intelligence software. We recently published a study comparing screen validation and microscopic reading of bone marrow aspirates. The aim of the current research will be the comparison between optical microscope reading and automatic pre-classification (AI based)

Interventions

  • Diagnostic test Blood cells classification
    Comparison of the classification of peripheral blood and bone marrow cells with optical microscope reading with pre-classification using Scopio technology (AI based)

Primary outcome measures

  • Optical microscope reading and automatic pre-classification [Time frame: 12 months]

Eligibility criteria

Inclusion criteria

  • Patients suffering from hemopathies with bone marrow aspirate assessable under the optical microscope

Exclusion criteria

  • Patients not affected by blood disorders
  • Patients suffering from hemopathies with bone marrow aspirate that cannot be assessed under the optical microscope

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

Italy · 1 center
  • Fondazione Policlinico Universitario A. Gemelli IRCCS — Roma

Identifiers

NCT: NCT06574308 · 6901

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗